Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
30 août 2024 07h00 HE
|
Purple Biotech Ltd.
REHOVOT, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that...
Alaska Energy Metals Debuts as Presenter at the Clean Energy Metals Virtual Investor Conference August 29th
28 août 2024 07h30 HE
|
Alaska Energy Metals Corporation
VANCOUVER, British Columbia, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Alaska Energy Metals (TSXV: AEMC) (OTCQB: AKEMF) (FRA: V7F) today announced its participation in the Clean Energy Metals Virtual...
Elev8 New Media to Participate in the 150th National Investment Banking Association Conference in Fort Lauderdale, Florida
27 août 2024 10h15 HE
|
Elev8 New Media
Elev8 New Media announced its participation as a sponsor of the NIBA's 150th Investment Conference.
InflaRx Announces Participation in September Investor Events
27 août 2024 07h30 HE
|
InflaRx N.V.
JENA, Germany, Aug. 27, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...
Singing Machine Announces Participation at The H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
26 août 2024 07h00 HE
|
The Singing Machine Company, Inc.
Fort Lauderdale, FL, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The Singing Machine Company, Inc. (“Singing Machine”) (NASDAQ: MICS) – the worldwide leader in consumer karaoke products, today announced it...
NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences
23 août 2024 16h03 HE
|
NurExone Biologic Inc
NurExone Biologic to present its innovative ExoPTEN therapy at key September conferences in Boston and New York, showcasing its leadership in regenerative
Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright, 9 au 11 septembre 2024
22 août 2024 01h30 HE
|
CROSSJECT
Communiqué de Presse Dijon, France, le 22 août 2024 07:30 CET — Crossject (ISIN : FR0011716265 ; Euronext : ALCJ), une société pharmaceutique spécialisée qui développe des médicaments dédiés aux...
Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024
22 août 2024 01h30 HE
|
CROSSJECT
Press Release Dijon, France August 22, 2024 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing medicines for emergency situations harnessing its...
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences
19 août 2024 16h05 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc.’s (Nasdaq: COCP) management announces its participation in the upcoming Virtual Investor Summit Microcap Forum in August and...
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
15 août 2024 12h13 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...